Idaho Statutes
§ 41-351 — 340B DRUG PRICING PROGRAM REPORTING
(1)As used in this section, "340B covered entity" means an entity authorized to participate in the federal 340B drug pricing program under section 340B(a)(4) of the federal public health service act.
(2)Before April 1 of each year, a 340B covered entity shall report the following information to the state department of health and welfare, the state controller’s office, and the attorney general concerning the 340B covered entity’s participation in the federal 340B drug pricing program for the previous calendar year:
(a)The name of the covered 340B entity;
(b)The aggregate acquisition cost for prescription drugs obtained under the 340B program;
(c)The aggregate payment amount received for drugs obtained under the 340B program and dispensed to patients;
(d)The aggregate payment made to p
Free access — add to your briefcase to read the full text and ask questions with AI
Idaho § 41-351 (340B DRUG PRICING PROGRAM REPORTING) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Legislative History
[41-351, added 2025, ch. 246, sec. 1, p. 1098.]
Nearby Sections
15
§ 41-1001
PURPOSE AND SCOPE§ 41-1002
TERMS CONSTRUED§ 41-1003
DEFINITIONS§ 41-1004
LICENSE REQUIRED§ 41-1005
EXCEPTIONS TO LICENSING§ 41-1006
APPLICATION FOR EXAMINATION§ 41-1007
APPLICATION FOR PRODUCER LICENSE§ 41-1008
PRODUCER LICENSE§ 41-1009
NONRESIDENT PRODUCER LICENSE§ 41-101
SHORT TITLE§ 41-1011
ISSUANCE — REFUSAL OF LICENSE§ 41-1012
EXEMPTION FROM EXAMINATION§ 41-1014
ASSUMED NAMES